Bimetallic Ca/Zn Nanoagonist Remould the Immunosuppressive Hepatocellular Carcinoma Microenvironment Following Incomplete Microwave Ablation via Pyroptosis and the STING Signaling Pathway
Source abstract
Abstract
Abstract During the treatment of solid tumors, local therapeutic approaches carry the risk of incomplete radical cure, which may lead to rapid tumor growth. Incomplete microwave ablation (iMWA) can induce tumors to exhibit highly invasive and uncontrollable growth, which is related to the immunosuppressive microenvironment. A multifunctional bimetallic Ca/Zn nanoagonist (PZH/Zn@CaNA) with a biomimetic liposome‐modified surface to tumor tissues after iMWA is developed. In response to the acidic tumor microenvironment, the released traditional Chinese medicine preparation Pien Tze Huang (PZH) reduced protein expressions of the JAK2‐STAT3 signaling pathway, thereby slowing down the proliferation and growth of hepatocellular carcinoma (HCC). Furthermore, the bimetallic ions Ca 2 ⁺ and Zn 2 ⁺ can cascade to enhance the killing effect of oxidative stress, generating substantial amounts of reactive oxygen species. This process induces pyroptosis and releases significant quantities of damage associated molecular patterns, thereby triggering immune activation mechanisms related to the STING pathway that reshape the immunosuppressive HCC microenvironment resulting from iMWA. This strategy markedly differs from previous chemoimmunotherapies, which not only effectively addressed the problem of conventional drugs showing heterogeneous distribution in tumor regions, but also verified the critical role played by PZH/Zn@CaNA in inhibiting iMWA‐induced rapid tumor growth, regulating oxidative stress and remodeling the immunosuppressive tumor microenvironment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer Mechanisms and Therapy · interferon and immune responses · Ferroptosis and cancer prognosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Hepatobiliary Surgery Department of Medical Ultrasound Department of Traditional Chinese Medicine Guangxi Medical University Cancer Hospital Guangxi Medical University. No. 71 Hedi Road Nanning Guangxi 530021 China
Center of Interventional Radiology & Vascular Surgery Department of Radiology Zhongda Hospital Medical School Southeast University Nanjing 210009 China
Funding
National Natural Science Foundation of China · China Postdoctoral Science Foundation · Specific Research Project of Guangxi for Research Bases and Talents
References (66)
Show source-provided references
1. 10.3322/caac.2176310.3322/caac.21763 ↗
2. 10.1016/j.biomaterials.2024.12301810.1016/j.biomaterials.2024.123018 ↗
3. 10.1002/adfm.20240814110.1002/adfm.202408141 ↗
4. 10.1021/acsnano.4c1125710.1021/acsnano.4c11257 ↗
5. 10.1007/s00432-016-2266-510.1007/s00432-016-2266-5 ↗
6. 10.1038/srep3272810.1038/srep32728 ↗
7. 10.1002/advs.20210461910.1002/advs.202104619 ↗
8. 10.1016/j.jconrel.2024.10.06910.1016/j.jconrel.2024.10.069 ↗
9. 10.1038/s41575-022-00704-910.1038/s41575-022-00704-9 ↗
10. 10.1002/advs.20241048410.1002/advs.202410484 ↗
11. 10.1016/j.cej.2024.15336810.1016/j.cej.2024.153368 ↗
12. 10.1002/advs.20240697510.1002/advs.202406975 ↗
13. 10.1038/s41467-024-54883-x10.1038/s41467-024-54883-x ↗
14. 10.1016/j.biomaterials.2024.12294410.1016/j.biomaterials.2024.122944 ↗
15. 10.1021/acsnano.2c1084510.1021/acsnano.2c10845 ↗
16. 10.1080/02656736.2023.219006510.1080/02656736.2023.2190065 ↗
17. 10.1002/cncr.2419610.1002/cncr.24196 ↗
18. 10.1016/j.bbadis.2024.16749310.1016/j.bbadis.2024.167493 ↗
19. 10.1021/jacs.3c1400510.1021/jacs.3c14005 ↗
20. 10.1021/acsnano.1c0561810.1021/acsnano.1c05618 ↗
21. 10.1038/s41467-022-30543-w10.1038/s41467-022-30543-w ↗
22. 10.1186/s12935-024-03578-w10.1186/s12935-024-03578-w ↗
23. 10.1002/advs.20220310610.1002/advs.202203106 ↗
24. 10.1021/acsnano.1c0882610.1021/acsnano.1c08826 ↗
25. 10.1016/j.trecan.2023.04.00110.1016/j.trecan.2023.04.001 ↗
26. 10.1016/j.ccell.2023.02.01610.1016/j.ccell.2023.02.016 ↗
27. 10.1002/advs.20210007410.1002/advs.202100074 ↗
28. 10.1186/s12951-024-02809-610.1186/s12951-024-02809-6 ↗
29. 10.1136/jitc-2022-00651610.1136/jitc-2022-006516 ↗
30. 10.1016/j.trecan.2024.02.00210.1016/j.trecan.2024.02.002 ↗
31. 10.1038/s43018-021-00291-910.1038/s43018-021-00291-9 ↗
32. 10.1016/j.bioactmat.2023.10.02310.1016/j.bioactmat.2023.10.023 ↗
33. 10.1021/acsnano.3c0593610.1021/acsnano.3c05936 ↗
34. 10.1002/adfm.20240311810.1002/adfm.202403118 ↗
35. 10.1021/acsami.3c1789110.1021/acsami.3c17891 ↗
36. 10.1038/s41467-022-33968-510.1038/s41467-022-33968-5 ↗
37. 10.1002/smll.20220322710.1002/smll.202203227 ↗
38. 10.1016/j.bioactmat.2021.10.04610.1016/j.bioactmat.2021.10.046 ↗
39. 10.1038/s41467-023-36614-w10.1038/s41467-023-36614-w ↗
40. 10.7150/thno.7108610.7150/thno.71086 ↗
41. 10.1186/s13046-021-02065-810.1186/s13046-021-02065-8 ↗
42. 10.1126/science.adm919010.1126/science.adm9190 ↗
43. 10.1016/j.scib.2023.02.02710.1016/j.scib.2023.02.027 ↗
44. 10.1186/s12943-024-02183-910.1186/s12943-024-02183-9 ↗
45. 10.1002/adma.20220937910.1002/adma.202209379 ↗
46. 10.1002/advs.20230214110.1002/advs.202302141 ↗
47. 10.1021/acsnano.2c0019210.1021/acsnano.2c00192 ↗
48. 10.1016/j.biomaterials.2024.12261010.1016/j.biomaterials.2024.122610 ↗
49. 10.1002/smll.20240025410.1002/smll.202400254 ↗
50. 10.1016/j.cell.2024.08.00710.1016/j.cell.2024.08.007 ↗
51. 10.1186/s12935-024-03428-910.1186/s12935-024-03428-9 ↗
52. 10.1053/j.gastro.2023.08.05210.1053/j.gastro.2023.08.052 ↗
53. 10.3892/or.2012.206710.3892/or.2012.2067 ↗
54. 10.1186/s12935-021-01785-310.1186/s12935-021-01785-3 ↗
55. 10.1186/s12935-023-02946-210.1186/s12935-023-02946-2 ↗
56. 10.1016/j.jpha.2023.12.00510.1016/j.jpha.2023.12.005 ↗
57. 10.1038/s41467-022-33831-710.1038/s41467-022-33831-7 ↗
58. 10.1002/adfm.20240996610.1002/adfm.202409966 ↗
59. 10.1016/j.bioactmat.2023.06.02210.1016/j.bioactmat.2023.06.022 ↗
60. 10.1002/smll.20240230810.1002/smll.202402308 ↗
61. 10.1038/s41392-021-00791-110.1038/s41392-021-00791-1 ↗
62. 10.1186/s12943-021-01377-910.1186/s12943-021-01377-9 ↗
63. 10.1002/adma.20200742610.1002/adma.202007426 ↗
64. 10.1021/acsnano.2c0801310.1021/acsnano.2c08013 ↗
65. 10.1016/j.actbio.2024.09.01510.1016/j.actbio.2024.09.015 ↗
66. 10.1016/j.bioactmat.2022.06.00510.1016/j.bioactmat.2022.06.005 ↗